| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Chen,Zheng | Chairman | 1.46% | |
| Zhu,Jia-Zhen | Director | 17.66% | Genovate Biotechnology Co., LTD. |
| Chen,De-Fang | Director | 0.00% | |
| Wang,Yu-Shan | Director | 0.23% | |
| Wang,Jia-Lin | Independent Director | 0.00% | |
| Xie,Ming-Juan | Independent Director | 0.00% | |
| Jian,He-Ying | Independent Director | 0.00% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 46,986 | 103,222 | 128,107 |
| Operating cost | 22,456 | 52,206 | 53,488 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 24,530 | 51,016 | 74,619 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 24,530 | 51,016 | 74,619 |
| Operating expenses | 38,533 | 78,321 | 95,495 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -14,003 | -27,305 | -20,876 |
| Non-operating income and expenses | 4,209 | 5,492 | 13,849 |
| Net profit (loss) before tax | -9,794 | -21,813 | -7,027 |
| Income tax expense (benefits) | 0 | 0 | 0 |
| Net profit (loss) of ongoing business for the current period | -9,794 | -21,813 | -7,027 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -9,794 | -21,813 | -7,027 |
| Other comprehensive profit (loss), net | 3,462 | 31,244 | 8,280 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -6,332 | 9,431 | 1,253 |
| Net profit (loss) attributable to owners of parent company | - | -21,813 | -6,446 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | 0 | -581 |
| Comprehensive profit (loss) attributable to owners of parent company | - | 9,431 | 1,834 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | 0 | -581 |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | 12,034 | -31,652 |
| Net cash inflows (outflows) from investing activities | - | -3,891 | -1,116 |
| Net cash inflow (outflow) from financing activities | - | -3,256 | 20,570 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | 4,887 | -12,198 |
| Beginning balance of cash and cash equivalents | - | 63,757 | 75,955 |
| Ending balance of cash and cash equivalents | - | 68,644 | 63,757 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 190,470 | 226,228 | 238,282 |
| Non-current asset | 146,040 | 123,846 | 94,292 |
| Total asset | 336,510 | 350,074 | 332,574 |
| Current liability | 17,240 | 37,116 | 28,775 |
| Non-current liability | 12,929 | 285 | 557 |
| Total liability | 30,169 | 37,401 | 29,332 |
| share capital | 355,010 | 355,010 | 355,010 |
| Equity - secruity token | - | - | - |
| capital reserve | 377 | 377 | 377 |
| retained earning | -70,712 | -60,918 | -40,344 |
| Other equity | 21,666 | 18,204 | -11,801 |
| Treasury stock | - | 0 | 0 |
| Total equity attributable to owners of parent company | - | 312,673 | 303,242 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | 0 | 0 |
| Total Equity | 306,341 | 312,673 | 303,242 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 8 | 8 | 8 |
